IEQ Capital’s Korro Bio KRRO Stock Holding History

IEQ Capital’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-21,246	Closed	-$280K	–	2105
2026 Q2	$280K	Buy	21,246 +8,469	+66%	+$105K	﹤0.01%	1677
2026 Q1	$145K	Buy	+12,777	New	+$141K	﹤0.01%	1754

Other funds holding KRRO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

KCM

Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

IEQ Capital's KRRO Position: Q3 2026 in Review

IEQ Capital sold out of Korro Bio (KRRO) in Q3 2026, closing a stake of 21,246 shares — an estimated $280K sold.

IEQ Capital first reported a position in KRRO in Q1 2026 and held it in 2 quarters. The position peaked at $280K in Q2 2026. 68 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

IEQ Capital reported no remaining Korro Bio position as of Q3 2026 after selling out during the quarter.
IEQ Capital sold 21,246 Korro Bio shares in Q3 2026, an estimated $280K.
IEQ Capital first reported a position in Korro Bio in Q1 2026 and held it in 2 quarters.
IEQ Capital's Korro Bio position peaked at $280K in Q2 2026.
68 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.